EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

Validation of the implementation of phased-array heating systems in Plan2Heat

H P Kok iD, J Crezee iD

Strahlentherapie und Onkologie · 2025

DOI: 10.1007/s00066-024-02264-0 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Strahlentherapie und Onkologie, 2025. Verfasst von H P Kok und 1 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam UMC, University of Amsterdam, Dept. Radiation Oncology, Cancer Center Amsterdam, Meibergdreef 9, 1105, AZ Amsterdam, The Netherlands. H.P.K…. Hauptthemen laut MEDLINE: Hyperthermia, Induced. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hyperthermia treatment planning can be supportive to ensure treatment quality, provided reliable prediction of the heating characteristics (i.e., focus size and effects of phase-amplitude and frequency steering) of the device concerned is possible. This study validates the predictions made by the treatment planning system Plan2Heat for various clinically used phased-array systems.

Methods

The evaluated heating systems were AMC-2, AMC-4/ALBA-4D (Med-Logix srl, Rome, Italy), BSD Sigma-30, and Sigma-60 (Pyrexar Medical, Salt Lake City, UT, USA). Plan2Heat was used for specific absorption rate (SAR) simulations in phantoms representing measurement set-ups reported in the literature. SAR profiles from published measurement data based on E‑field or temperature rise were used to compare the device-specific heating characteristics predicted by Plan2Heat.

Results

Plan2Heat is able to predict the correct location and size of the SAR focus, as determined by phase-amplitude settings and operating frequency. Measured effects of phase-amplitude steering on focus shifts (i.e., local SAR minima or maxima) were also correctly reflected in treatment planning predictions. Deviations between measurements and simulations were typically < 10–20%, which is within the range of experimental uncertainty for such phased-array measurements.

Conclusion

Plan2Heat is capable of adequately predicting the heating characteristics of the AMC‑2, AMC-4/ALBA-4D, BSD Sigma-30, and Sigma-60 phased-array systems routinely used in clinical hyperthermia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperthermia, InducedHumansEquipment DesignEquipment Failure AnalysisReproducibility of ResultsComputer SimulationPhantoms, ImagingSensitivity and SpecificityHeating

Stichwörter der Autor:innen

Electromagnetic heatingLocoregional hyperthermiaModelingPlan2HeatValidation

Autor:innen und Institutionen

  • Amsterdam UMC, University of Amsterdam, Dept. Radiation Oncology, Cancer Center Amsterdam, Meibergdreef 9, 1105, AZ Amsterdam, The Netherlands. H.P.Kok@amsterdamumc.nl.
  • Cancer Center Amsterdam, Treatment and quality of life, Cancer biology and immunology, Amsterdam, The Netherlands. H.P.Kok@amsterdamumc.nl.
  • Amsterdam UMC, University of Amsterdam, Dept. Radiation Oncology, Cancer Center Amsterdam, Meibergdreef 9, 1105, AZ Amsterdam, The Netherlands.
  • Cancer Center Amsterdam, Treatment and quality of life, Cancer biology and immunology, Amsterdam, The Netherlands.

ORCID-Profile: H P Kok, J Crezee

Zitieren

APA

Kok, H. P., & Crezee, J. (2025). Validation of the implementation of phased-array heating systems in Plan2Heat. Strahlentherapie und Onkologie. https://doi.org/10.1007/s00066-024-02264-0

Vancouver

Kok HP, Crezee J. Validation of the implementation of phased-array heating systems in Plan2Heat. Strahlentherapie und Onkologie. 2025. doi:10.1007/s00066-024-02264-0

BibTeX
@article{Kok2025,
  author = {Kok, H P and Crezee, J},
  title = {Validation of the implementation of phased-array heating systems in Plan2Heat},
  journal = {Strahlentherapie und Onkologie},
  year = {2025},
  doi = {10.1007/s00066-024-02264-0}
}
Kostenlos starten →